7ACC2: Carboxycoumarin MCT1 Inhibitor for Cancer Metabolism Research

Executive Summary: 7ACC2 is a carboxycoumarin derivative and a potent inhibitor of monocarboxylate transporter 1 (MCT1), displaying an IC50 of ~10 nM for lactate uptake inhibition in SiHa cancer cells (APExBIO product page). The compound also blocks mitochondrial pyruvate transport, presenting a dual mechanism that disrupts lactate and pyruvate flux in tumor cells (Xiao et al., 2024). In vivo, 7ACC2 delays tumor growth and enhances radiosensitivity in SiHa xenograft models. It is insoluble in water and ethanol but highly soluble in DMSO (≥47.5 mg/mL), and must be stored at -20°C. 7ACC2 is distributed by APExBIO for research use only, not for diagnostic or medical applications.

Biological Rationale

The monocarboxylate transporter (MCT) family comprises 14 members, with MCT1-4 mediating proton-linked transport of short-chain monocarboxylates such as lactate and pyruvate across cell membranes (Xiao et al., 2024). MCT1 and MCT4 are predominantly expressed in cancer cells, supporting the high glycolytic rates observed in tumors. MCT1 has a higher affinity for L-lactate, facilitating its uptake into oxidative tumor cells and contributing to metabolic symbiosis within the tumor microenvironment. Disrupting lactate and pyruvate transport via MCT1 inhibition is a validated approach for interfering with tumor metabolism, immune evasion, and progression (see detailed mechanism).

Mechanism of Action of 7ACC2

7ACC2 (C18H15NO4, MW 309.32) is a selective MCT1 inhibitor with nanomolar potency. In SiHa cervical carcinoma cells, 7ACC2 inhibits L-lactate uptake with an IC50 of ~10 nM, disrupting the transport of lactate and altering cellular redox balance. In addition to MCT1 inhibition, 7ACC2 blocks mitochondrial pyruvate import, further restricting substrate availability for oxidative phosphorylation in tumor cells. This dual inhibition results in decreased tumor cell viability and increased sensitivity to radiotherapy. The compound’s action has been validated in vitro and in vivo, including in mouse xenograft models (APExBIO).

Evidence & Benchmarks

• 7ACC2 inhibits lactate uptake in SiHa cells with an IC50 of ~10 nM at 37°C, pH 7.4 (APExBIO).
• In vivo administration of 7ACC2 in SiHa xenograft mouse models delays tumor growth when combined with radiotherapy (Xiao et al., 2024, DOI:10.1016/j.immuni.2024.03.021).
• 7ACC2 blocks mitochondrial pyruvate transport, reducing the entry of extracellular lactate-derived carbon into the TCA cycle (see workflow discussion).
• Inhibition of MCT1 by 7ACC2 perturbs the metabolic support provided by tumor-associated macrophages (TAMs), which rely on lactate flux for immunosuppressive reprogramming (Xiao et al., 2024).
• 7ACC2 is insoluble in ethanol and water but dissolves in DMSO at ≥47.5 mg/mL at 20°C (manufacturer specification, APExBIO).

Applications, Limits & Misconceptions

7ACC2 enables precise interrogation of lactate and pyruvate transport pathways in cancer metabolism research. It is used for:

• Dissecting metabolic dependencies of cancer cells and tumor-infiltrating immune cells.
• Modeling metabolic symbiosis and competition in the tumor microenvironment (comparison article—this article provides updated application boundaries).
• Enhancing radiosensitivity in preclinical cancer models.
• Validating immunometabolic checkpoints involved in tumor-associated macrophage function.

Common Pitfalls or Misconceptions

• 7ACC2 does not inhibit all MCT family members; its selectivity is highest for MCT1.
• It is not suitable for in vivo studies requiring water or ethanol as solvents, due to solubility constraints.
• Long-term storage of 7ACC2 solutions is not recommended; fresh DMSO solutions should be prepared before use.
• 7ACC2 is for research use only and is not intended for diagnostic or therapeutic applications.
• Biological effects may vary across cell lines expressing different levels of MCT1 and mitochondrial pyruvate carriers.

Workflow Integration & Parameters

For laboratory workflows, 7ACC2 should be dissolved in DMSO to create a ≥47.5 mg/mL stock solution. The compound is supplied by APExBIO (SKU B4868) and should be stored at -20°C. Stocks are stable for short-term use but should not be stored long-term. It is recommended to use blue ice shipping to maintain compound integrity. Concentrations used in cell-based assays typically range from 1 nM to 1 µM, with appropriate vehicle controls. For in vivo studies, formulation in DMSO with suitable co-solvents may be required for effective delivery (guidance article—this article details updated handling protocols for dual-inhibition studies).

Conclusion & Outlook

7ACC2 is a validated molecular tool for disrupting lactate and pyruvate transport in cancer metabolism research. Its dual inhibition mechanism enables advanced studies of tumor metabolic dependencies and immune evasion. As immunometabolic checkpoints gain prominence, 7ACC2 offers a robust avenue for dissecting metabolic crosstalk in the tumor microenvironment. For full specifications and ordering, consult the APExBIO 7ACC2 product page.